Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu • (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.
The mechanism of widespread reorganization of DNA methylation may be a therapeutic target to prevent or reverse dyskinesia.
Chang, who was named a 2015 Fulbright Scholar in 2015, is this year one of 57 Phi Kappa Phi fellows selected nationwide.
Researchers have found that an interaction between a mutant gene and alpha synuclein in neurons leads to hallmark pathologies seen in Parkinson’s disease, findings that may lead to new mechanisms and targets for neuroprotection.
A quality-control checkpoint in pre-B cells restricts the range of antibodies produced by mature B cells, and manipulation of the checkpoint could make vaccines more potent.
The iKnife, a revolutionary mass spectrometry method, contributes to precision surgery by allowing accurate identification of cancer margins.
The ecRNAs appear to act in memory formation, and may offer a new therapeutic approach to neuropsychiatric diseases.
The biomarker, the protein kinase LRRK2, is a promising candidate for future exploration.
A survival advantage for female humans stands out in a UAB review of sex differences in longevity across many species. Understanding why could inform treatments to extend healthy lifespans.
A robotic 3-D printer will build the tissue through computer-assisted design and computer-assisted manufacturing, but using living cells as the pieces of the structure.
This competitive award recognizes outstanding achievements and contributions to VA research and provides five years of salary support.